Back to search

Article

Asarinin alleviates hepatic fibrosis through TRα-STAT3 pathway: A new strategy by regulating liver microenvironment

2025-03-29

Abstract excerpt

<h4>Background: </h4> and Purpose: Hepatic fibrosis is the final pathological consequence of a wide spectrum of chronic liver disease. Asarinin (ASA) has shown biological effects in various liver disorders. This study explores the hepatoprotective effects of ASA, particularly the potential mechanism. Experimental Approach: Hepatic fibrosis model was established by intraperitoneal injection of TAA in C57BL/6 mice,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
adcc17e6-3ec7-5901-bd16-c58403e99e73
DOI
10.22541/au.174324107.72136341/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Asarinin alleviates hepatic fibrosis through TRα-STAT3 pathway: A new strategy by regulating liver microenvironmentDOI 10.22541/au.174324107.72136341/v1
Select a neighboring publication to make it the new centre.